DK21579A - 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling - Google Patents

5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling

Info

Publication number
DK21579A
DK21579A DK21579A DK21579A DK21579A DK 21579 A DK21579 A DK 21579A DK 21579 A DK21579 A DK 21579A DK 21579 A DK21579 A DK 21579A DK 21579 A DK21579 A DK 21579A
Authority
DK
Denmark
Prior art keywords
oxazolidon
phenethyl
derivatives
procedure
preparation
Prior art date
Application number
DK21579A
Other languages
English (en)
Inventor
Y Fujimoto
T Tamada
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of DK21579A publication Critical patent/DK21579A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/04—Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/08—Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK21579A 1978-01-20 1979-01-18 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling DK21579A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53004333A JPS6014032B2 (ja) 1978-01-20 1978-01-20 ５‐フエネチル‐２‐オキサゾリドン誘導体およびその製法

Publications (1)

Publication Number Publication Date
DK21579A true DK21579A (da) 1979-07-21

Family

ID=11581515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK21579A DK21579A (da) 1978-01-20 1979-01-18 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling

Country Status (7)

Country Link
US (1) US4236012A (da)
JP (1) JPS6014032B2 (da)
DE (1) DE2902129A1 (da)
DK (1) DK21579A (da)
FR (1) FR2415107A1 (da)
GB (1) GB2012750B (da)
IT (1) IT7967130A0 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0416216U (da) * 1990-06-01 1992-02-10
AU646871B2 (en) * 1990-06-07 1994-03-10 Astrazeneca Uk Limited Therapeutic heterocyclic compounds
JPH04129243U (ja) * 1991-05-15 1992-11-25 八ツ藤工業有限会社 連結式手すり棒
EP0530812B1 (en) * 1991-09-05 1996-05-22 Nippon Paint Co., Ltd. Thermosetting resinous composition containing polyfunctional oxazolidinone component and polyamine component
TW223669B (da) * 1992-07-24 1994-05-11 Hoechst Ag
CZ200788A3 (cs) * 1996-04-11 2017-01-25 Pfizer Inc. Způsob přípravy 5-aminomethyl substituovaných oxazolidinonaminů
DE19723498C1 (de) * 1997-06-05 1998-07-09 Goldschmidt Ag Th 2-Oxazolidinongruppen enthaltende Organosilane und Organopolysiloxane, deren Verwendung als grenzflächenaktive Substanzen sowie deren Verwendung zur Herstellung Amino- oder Carbamidgruppen enthaldender Organosilane und Organopolysiloxane

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4062862A (en) * 1975-07-04 1977-12-13 Nippon Chemiphar Co., Ltd. 5-Benzyl-2-oxazolidone derivatives and a process for producing the same

Also Published As

Publication number Publication date
GB2012750A (en) 1979-08-01
JPS54100367A (en) 1979-08-08
DE2902129A1 (de) 1979-07-26
US4236012A (en) 1980-11-25
JPS6014032B2 (ja) 1985-04-11
FR2415107A1 (fr) 1979-08-17
GB2012750B (en) 1982-05-06
FR2415107B1 (da) 1982-07-02
IT7967130A0 (it) 1979-01-19

Similar Documents

Publication Publication Date Title
DK338379A (da) Pyrazinderivater og fremgangsmaade til deres fremstilling
NO150634C (no) Sementholdige blandinger og fremgangsmaate for deres fremstilling
NO793993L (no) Nye silyl-glucoseaminderivater og fremgangsmaate til deres fremstilling
DK522578A (da) G prostacyklinderivater og fremgangsmaade til deres fremstillin
DK83679A (da) Eddikesyrederivater og fremgangsmaade til deres fremstilling
NO790934L (no) 2,6-dialkoksybenzamider og fremgangsmaate til deres fremstilling
DK401882A (da) Cyclopentadienderivater og fremgangsmaader til deres fremstilling
DK401679A (da) Furanderivater og fremgangsmaade til fremstilling deraf
DK409277A (da) Pentapeptider og fremgangsmaade til deres fremstilling
DK582578A (da) 2,4-thiazolidindion-derivater og fremgangsmaade til deres fremstilling
DK308878A (da) Aminoglyosidderivater og fremgangsmaader til deres fremstilling
DK111678A (da) Enzym-marumer og fremgangsmaade til deres fremstilling
DK21579A (da) 5-phenethyl-2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK270077A (da) 6,7-benzomorphanderivater og fremgangsmade til deres fremstillling
NO790047L (no) Kompoundmaterialer og fremgangsmaate til deres fremstilling
DK161377A (da) Naphtyridinderivater og fremgangsmade til deres fremstilling
DK118879A (da) 2-hydroxymethyl-pyrazin-derivater og fremgangsmaade til deres fremstilling
DK416278A (da) 2-oxazolidon-derivater og fremgangsmaade til deres fremstilling
DK334079A (da) Anthraquinon-derivater og fremgangsmaade til deres fremstilling
DK24280A (da) Spiro-quinolylhydantoiner fremgangsmaade til deres fremstilling og deres anvendelse
NO821206L (no) Imidazolderivater og fremgangsmaate for deres fremstilling
NO791520L (no) Substituerte antitumorantracycliner og fremgangsmaate for deres fremstilling
DK329078A (da) Oleandomycinderivater og fremgangsmaade til deres fremstilling
DK566978A (da) Phosphoramidothioat-derivater deres fremstilling og anvendelse
DK258179A (da) L-cysteinderivater og fremgangsmaade til deres fremstilling